Germany-based biotech company, CatalYm, has closed an oversubscribed US$150m Series D financing. Founded in 2016 with support from Forbion and BGV, CatalYm is a leader in the development in a…
Germany: CatalYm closes oversubscribed Series D financing
…
…






